Cite
HARVARD Citation
Feld, J. et al. (2021). Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies. HemaSphere. 5 (4), pp. e549-. [Online].